Mirzaei Rasoul, Esmaeili Gouvarchin Ghaleh Hadi, Ranjbar Reza
Department of Microbiology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Applied Virology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Front Microbiol. 2023 Feb 20;14:1030401. doi: 10.3389/fmicb.2023.1030401. eCollection 2023.
Multidrug-resistant (MDR) pathogens are being recognized as a critical threat to human health if they can form biofilm and, in this sense, biofilm-forming MDR-methicillin resistant (MRSA) and - strains are a worse concern. Hence, a growing body of documents has introduced antimicrobial peptides (AMPs) as a substitute candidate for conventional antimicrobial agents against drug-resistant and biofilm-associated infections. We evaluated melittin's antibacterial and antibiofilm activity alone and/or in combination with gentamicin, ciprofloxacin, rifampin, and vancomycin on biofilm-forming MDR- and MDR-MRSA strains.
Antibacterial tests [antibiogram, minimum inhibitory concentration (MIC), and minimum bactericidal concentration (MBC)], anti-biofilm tests [minimum biofilm inhibition concentration (MBIC), and minimum biofilm eradication concentration (MBEC)], as well as synergistic antibiofilm activity of melittin and antibiotics, were performed. Besides, the influence of melittin alone on the biofilm encoding genes and the cytotoxicity and hemolytic effects of melittin were examined.
MIC, MBC, MBIC, and MBEC indices for melittin were in the range of 0.625-5, 1.25-10, 2.5-20, and 10-40 μg/ml, respectively. The findings found that the combination of melittin AMP with antibiotics was synergistic and fractional biofilm inhibitory concentration index (FBICi) for most tested concentrations was <0.5, resulting in a significant reduction in melittin, gentamicin, ciprofloxacin, vancomycin, and rifampin concentrations by 2-256.4, 2-128, 2-16, 4-64 and 4-8 folds, respectively. This phenomenon reduced the toxicity of melittin, whereby its synergist concentration required for biofilm inhibition did not show cytotoxicity and hemolytic activity. Our findings found that melittin decreased the expression of in and in genes from 0.1 to 4.11 fold for , and 0.11 to 3.7 fold for , respectively.
Overall, the results obtained from our study show that melittin alone is effective against the strong biofilm of MDR pathogens and also offers sound synergistic effects with antibiotics without toxicity. Hence, combining melittin and antibiotics can be a potential candidate for further evaluation of infections by MDR pathogens.
如果多重耐药(MDR)病原体能够形成生物膜,它们就被认为是对人类健康的重大威胁,从这个意义上说,形成生物膜的耐甲氧西林多药耐药(MRSA)和 - 菌株更令人担忧。因此,越来越多的文献将抗菌肽(AMPs)作为对抗耐药和生物膜相关感染的传统抗菌剂的替代候选物。我们评估了蜂毒素单独和/或与庆大霉素、环丙沙星、利福平及万古霉素联合使用时,对形成生物膜的MDR - 和MDR - MRSA菌株的抗菌和抗生物膜活性。
进行了抗菌测试[抗菌谱、最低抑菌浓度(MIC)和最低杀菌浓度(MBC)]、抗生物膜测试[最低生物膜抑制浓度(MBIC)和最低生物膜根除浓度(MBEC)]以及蜂毒素与抗生素的协同抗生物膜活性测试。此外,还研究了单独使用蜂毒素对生物膜编码基因的影响以及蜂毒素的细胞毒性和溶血作用。
蜂毒素的MIC、MBC、MBIC和MBEC指数分别在0.625 - 5、1.25 - 10、2.5 - 20和10 - 40μg/ml范围内。研究结果发现,蜂毒素抗菌肽与抗生素联合使用具有协同作用,大多数测试浓度下的部分生物膜抑制浓度指数(FBICi)<0.5,导致蜂毒素、庆大霉素、环丙沙星、万古霉素和利福平的浓度分别显著降低2 - 256.4、2 - 128、2 - 16、4 - 64和4 - 8倍。这种现象降低了蜂毒素的毒性,因此其抑制生物膜所需的协同浓度未显示出细胞毒性和溶血活性。我们的研究结果发现,蜂毒素使生物膜编码基因中的 和 基因的表达分别降低了0.1至4.11倍(对于 )和0.11至3.7倍(对于 )。
总体而言,我们研究获得的结果表明,蜂毒素单独对MDR病原体的强大生物膜有效,并且与抗生素联合使用时也具有良好的协同作用且无毒性。因此,将蜂毒素与抗生素联合使用可能是进一步评估MDR病原体感染的潜在候选方案。